Article

What Can We Expect From Long-Acting Formulations for Schizophrenia?

Division of Translational Neuroscience, Department of Psychiatry, University of Pennsylvania, Translational Research Laboratories, Philadelphia, PA 19104, USA.
Current Psychiatry Reports (Impact Factor: 3.05). 05/2011; 13(4):243-4. DOI: 10.1007/s11920-011-0206-2
Source: PubMed
0 Followers
 · 
114 Views
 · 
0 Downloads